The contractor shall evaluate compounds for anticancer activity in experimental in vivo tumor models. Studies shall focus on agents identified by the Program's disease-oriented in vitro drug screen, and shall employ human tumors growing in immune-deficient mice. Experiments shall be designed and conducted to optimize drug activity, and evaluate the drug's therapeutic potential.

Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM057207-000
Application #
2300852
Study Section
Project Start
1995-02-16
Project End
1998-02-15
Budget Start
1995-02-16
Budget End
1996-02-15
Support Year
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Southern Research Institute
Department
Type
DUNS #
006900526
City
Birmingham
State
AL
Country
United States
Zip Code
35205